13,139 resources
Start Prev Rows 12200 - 12400 Next
Package | Version | Identity | Name/Title | Status | FMM | WG | Date | Auth | Source(s) |
---|---|---|---|---|---|---|---|---|---|
us.nlm.vsac | R4 | 2.16.840.1.113883.1.11.12212 | Marital Status | active | 2024-06 | hl7 | tho | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.11.20.9.33 | INDRoleclassCodes | active | 2024-06 | hl7 | tho | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.88.12.80.64 | Medication Fill Status | active | 2024-06 | hl7 | tho | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.11.20.9.18 | MoodCodeEvnInt | active | 2024-06 | hl7 | tho | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.11.20.9.25 | Planned moodCode (Observation) | active | 2024-06 | hl7 | tho | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.11.20.9.24 | Planned moodCode (SubstanceAdministration/Supply) | active | 2024-06 | hl7 | tho | ||
fhir.kenyaPSIG | R4 | medication-vs | Medication Value Set | draft | 2025-07 | hl7 | sct | ||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3392 | Value Type (IIS) | active | 2018-01 | tho | |||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1108.101 | Myocardial Infarction | active | 2024-02 | hl7 | vsac | ||
hl7.fhir.us.breastcancer | R3 | oncology-HER2FISHMethodVS | BC HER2FISHMethodVS ValueSet | draft | 2018-08 | hl7 | sct | ||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.8001 | Time of Day (CDC) | active | 2020-01 | sct | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7265 | Duration Unit | active | 2020-01 | ucum tho | |||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1213.110 | Corticosteroid Ingredients and Risk of GI Bleeding | active | 2023-12 | hl7 | rx | ||
hl7.fhir.us.breastcancer | R3 | oncology-HER2byIHCScoreVS | BC HER2byIHCScoreVS ValueSet | draft | 2018-08 | hl7 | loinc | ||
hl7.fhir.us.breastcancer | R3 | shr-core-PositiveNegativeVS | BC PositiveNegativeVS ValueSet | draft | 2018-08 | hl7 | sct | ||
hl7.fhir.us.breastcancer | R3 | shr-core-PositiveNegativeIndeterminateVS | BC PositiveNegativeIndeterminateVS ValueSet | draft | 2018-08 | hl7 | sct | ||
hl7.fhir.us.mcode | R4 | mcode-lansky-play-performance-vs | Lansky Play Performance Status VS | active | cic | 2025-02 | hl7 | ncit | |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1260.249 | pralsetinib | active | 2024-06 | hl7 | rx | ||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7777 | Healthcare Service Location (Syndromic) | active | 2020-01 | cdc | |||
hl7.fhir.us.physical-activity | R4 | pa-goal-target-measure | PA Goal Target Measure Codes | informative | pc | 2024-03 | hl7 | fhir | |
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.954 | BioSense Observations | active | 2008-01 | oid loinc | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7333 | Timing of Maternal Treatment (NND) | active | 2015-01 | sct tho | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3045 | Microorganism (Hepatitis) | active | 2016-01 | sct | |||
hl7.fhir.us.odh | R4 | obf-datatype-YesNoVS | Yes No VS | draft | 2020-01 | hl7 | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.6062 | Observation Result Status Interpretation Codes | active | 2012-01 | tho | |||
hl7.fhir.us.pq-cmc-fda | R5 | cmc-comp-section-types-vs | eCTD sections Terminology | trial-use | 2 | brr | 2025-07 | hl7 | tho |
hl7.fhir.us.pco | R4 | pco-goal-domain-categories | PCO Goal Domain Categories | draft | 2 | pc | 2025-08 | hl7 | fhir |
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7911 | Clinical sample or isolate (ARLN) | active | 2019-01 | sct oid | |||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1166.22 | Pregnancy Intention | active | 2023-08 | hl7 | sct | ||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7228 | CSF WBC Protein Result (NND) | active | 2020-01 | sct tho oid | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7950 | Yes No Unknown NA (NND) | active | 2020-01 | tho | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7486 | Yes No Not Applicable (NCHS) | active | 2017-01 | tho | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.888 | Yes No Unknown (YNU) | active | 2008-01 | tho | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7193 | YNRD (CDC) | active | 2020-01 | tho oid | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.819 | Yes No Indicator (HL7) | active | 2018-12 | tho | |||
fhir.r4.nhsengland.programme | R4 | England-Endpoint-BusinessScenario | England Endpoint Business Scenario | draft | 2025-07 | hl7 | |||
fhir.nigeriaImmunization | R4 | IMMZD16-ValueSet | IMMZ.E.DE.5 ValueSet for AEFI Treatment | active | 2025-08 | hl7 | internal | ||
fhir.nigeriaImmunization | R4 | vaccine-diluent-vs | IMMZI - ValueSet for Vacine Stock Levels | active | 2025-08 | hl7 | internal | ||
fhir.nigeriaImmunization | R4 | neir-substance-vs | NEIR ValueSet for Allowed Allergy-related Substances | active | 2025-08 | hl7 | internal | ||
fhir.nigeriaImmunization | R4 | IMMZ.F.DE2 | IMMZ.G.DE2 ValueSet for Client Sex | active | 2025-08 | hl7 | internal | ||
fhir.nigeriaImmunization | R4 | neir-clinical-status-vs | NEIR ValueSet for Clinical Status | active | 2025-08 | hl7 | tho | ||
fhir.nigeriaImmunization | R4 | IMMZDContraindications | IMMZ.D.DE11 ValueSet for Contraindications | active | 2025-08 | hl7 | internal | ||
fhir.nigeriaImmunization | R4 | DeviceMaterialCodeVS | Device Material ValueSet | active | 2025-08 | hl7 | internal | ||
fhir.nigeriaImmunization | R4 | IMMZHDisaggregationGroup | IMMZ.H.DE42 ValueSet for Disaggregation Group | active | 2025-08 | hl7 | internal | ||
fhir.nigeriaImmunization | R4 | IMMZDFacilityType | IMMZ.D.DE2 ValueSet for Facility Type | active | 2025-08 | hl7 | internal | ||
fhir.nigeriaImmunization | R4 | immzc1-hiv-status-vs | IMMZ.C.DE37 ValueSet for HIV Status | active | 2025-08 | hl7 | internal | ||
fhir.nigeriaImmunization | R4 | NEIRImmunizationNotDoneReasonsVS | NEIR ValueSet for Immunization Not Done | active | 2025-08 | hl7 | internal | ||
fhir.nigeriaImmunization | R4 | IMMZ.F.DE6 | IMMZ.G.DE6 ValueSet for missed immunization | active | 2025-08 | hl7 | internal | ||
fhir.nigeriaImmunization | R4 | pregnancy-status-vs | IMMZ.C.DE41 ValueSet for Pregnancy Status | draft | 2025-08 | hl7 | sct | ||
fhir.nigeriaImmunization | R4 | IMMZHReportdicaredType | IMMZ.H.DE22 ValueSet for Report Discarded types | active | 2025-08 | hl7 | internal | ||
fhir.nigeriaImmunization | R4 | IMMZHReportImprovementIndicator | IMMZ.H.DE34 ValueSet for Report Improvement Indicator | active | 2025-08 | hl7 | internal | ||
fhir.nigeriaImmunization | R4 | IMMZDReportIndicatorCode | IMMZ.H.DE10 ValueSet for Report Indicator Code | active | 2025-08 | hl7 | internal | ||
fhir.nigeriaImmunization | R4 | IMMZHReportStatus | IMMZ.H.DE2 ValueSet for Report Status | active | 2025-08 | hl7 | internal | ||
fhir.nigeriaImmunization | R4 | IMMZHReportType | IMMZ.H.DE10 ValueSet for Report Indicator Code | active | 2025-08 | hl7 | internal | ||
fhir.nigeriaImmunization | R4 | IMMZDRouteOfAdministration | IMMZ.D.DE27 ValueSet for Route of Administration | active | 2025-08 | hl7 | internal | ||
fhir.nigeriaImmunization | R4 | neir-service-request-vs | NEIR ValueSet for Service Request | active | 2025-08 | hl7 | internal | ||
fhir.nigeriaImmunization | R4 | IMMZDSessionType | IMMZ.D.DE6 ValueSet for Session Type | active | 2025-08 | hl7 | internal | ||
fhir.nigeriaImmunization | R4 | IMMZDSiteAdministered | IMMZ.D.DE21 ValueSet for Site Administered | active | 2025-08 | hl7 | internal | ||
fhir.nigeriaImmunization | R4 | IMMZH-ValueSet | IMMZ.I ValueSet for Stock Management | active | 2025-08 | hl7 | internal | ||
fhir.nigeriaImmunization | R4 | IMMZFVaccineType | IMMZ.D.DE10 ValueSet for Vaccine Type | active | 2025-08 | hl7 | internal | ||
fhir.nigeriaImmunization | R4 | neir-verification-status-vs | NEIR ValueSet for Verification Status | active | 2025-08 | hl7 | tho | ||
fhir.nigeriaImmunization | R4 | relatedPersonRelationshiptype-vs | IMMZ.F.DE2 ValueSet for Client Relationship | draft | 2025-08 | hl7 | tho | ||
fhir.nigeriaImmunization | R4 | NEIRFacilityTypeVS | NEIR ValueSet for Facility Types | active | 2025-08 | hl7 | internal | ||
fhir.nigeriaImmunization | R4 | gender-vs | IMMZ.C.DE5 ValueSet for Gender | draft | 2025-08 | hl7 | fhir | ||
fhir.kenyaPSIG | R4 | gender-vs | Gender ValueSet | draft | 2025-07 | hl7 | sct | ||
fhir.nigeriaImmunization | R4 | immunization-encounter-class-vs | NEIR ValueSet for Immunization Encounter | active | 2025-08 | hl7 | tho | ||
fhir.nigeriaImmunization | R4 | NEIRSessionTypeVS | NEIR ValueSet for Session Types | active | 2025-08 | hl7 | internal | ||
fhir.nigeriaImmunization | R4 | state-of-health-of-other-children-vs | IMMZ.C.DE31 ValueSet for State of Health of Mother's Other Children | active | 2025-08 | hl7 | |||
fhir.tx.support.r4 | R4 | MDC-dimension | MDC Unit of Measurement | active | hl7 | iso | |||
fhir.tx.support.r4 | R4 | MDC-metric | MDC Metric nomenclature | active | hl7 | iso | |||
fhir.tx.support.r4 | R4 | MDC-object | MDC Object infrastructure and Device nomenclature | active | hl7 | iso | |||
fhir.tx.support.r4 | R4 | MDC | MDC Nomenclature | active | hl7 | iso | |||
fhir.tx.support.r4 | R4 | MDC-partition | MDC Partition codes | active | hl7 | iso | |||
fhir.nigeriaImmunization | R4 | NEIRVaccineCodesVS | NEIR ValueSet for vaccine codes | active | 2025-08 | hl7 | internal | ||
hl7.fhir.us.registry-protocols | R4 | HealthInsurancePaymentSource | Health Insurance Payment Source | active | cic | 2023-11 | hl7 | fhir | |
fhir.outburn.co.il | R4 | practitioner-expert-occupation | Practitioner Expert Occupation | draft | hl7 | ||||
fhir.outburn.co.il | R4 | practitioner-occupation | Practitioner Occupation | draft | hl7 | ||||
fhir.dgmc | R4 | hospitals-uris-cml-answer | Hospitals Uris Chameleon Answer | draft | 2024-07 | hl7 | |||
fhir.dgmc | R4 | hospitals-uris-cml-request | Hospitals Uris Chameleon Request | draft | 2024-07 | hl7 | |||
fhir.dgmc | R4 | hospitals-uris-cml-medical-record | Hospitals Uris Chameleon Medical Record | draft | 2024-07 | hl7 | |||
fhir.dgmc | R4 | hospitals-uris-cml-pat-int | Hospitals Uris Chameleon Patient Internal | draft | 2024-07 | hl7 | |||
fhir.dgmc | R4 | hospitals-uris-Enc-Diet-Pref | Hospitals Uris Encounter Diet Preference | draft | 2024-07 | hl7 | |||
fhir.dgmc | R4 | hospitals-uris-Nmr-Case-Num | Hospitals Uris Namer Case Number | draft | 2024-07 | hl7 | |||
fhir.dgmc | R4 | hospitals-uris-nmr-pat-int | Hospitals Uris Namer Patient Internal | draft | 2024-07 | hl7 | |||
fhir.dgmc | R4 | hospitals-uris-nmr-pat-tmp | Hospitals Uris Namer Patient Temp | draft | 2024-07 | hl7 | |||
fhir.dgmc | R4 | hospitals-uris-Nmr-To-Cml-Ident | Hospitals Uris Maner to Chameleon Identifier | draft | 2024-07 | hl7 | |||
fhir.org.nz.ig.base | R4 | acc-patient-occupation-valueset | ACC Patient Occupation | active | 2025-06 | hl7 | |||
hl7.fhir.us.mcode | R4 | mcode-history-of-metastatic-malignant-neoplasm-vs | History of Metastatic Malignant Neoplasm Value Set | active | cic | 2025-02 | hl7 | sct | |
hl7.fhir.us.breastcancer | R3 | oncology-LymphNodeMobilityVS | BC LymphNodeMobilityVS ValueSet | draft | 2018-08 | hl7 | sct | ||
hl7.fhir.us.mcode | R4 | mcode-tnm-stage-group-max-vs | TNM Stage Group Maximum Value Set | active | cic | 2025-02 | hl7 | fhir | |
hl7.fhir.us.mcode | R4 | mcode-figo-stage-value-vs | FIGO Stage Value Set | active | cic | 2025-02 | hl7 | ncit | |
hl7.fhir.us.mcode | R4 | mcode-tnm-distant-metastases-category-max-vs | TNM Distant Metastases Maximum Value Set | active | cic | 2025-02 | hl7 | fhir | |
hl7.fhir.us.mcode | R4 | mcode-tnm-primary-tumor-category-max-vs | TNM Primary Tumor Maximum Value Set | active | cic | 2025-02 | hl7 | fhir | |
hl7.fhir.us.mcode | R4 | mcode-tnm-regional-nodes-category-max-vs | TNM Regional Nodes Maximum Value Set | active | cic | 2025-02 | hl7 | fhir | |
hl7.fhir.us.mcode | R4 | mcode-cancer-staging-prognostic-factor-value-vs | Cancer Staging Prognostic Factors Value | active | cic | 2025-02 | hl7 | sct | |
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7951 | Reason for Test (COVID-19) | active | 2020-01 | sct tho oid | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.929 | Positive Negative Unknown Not Done | active | 2008-01 | sct tho | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.1000 | Identity Reliability Code (HL7) | active | 2008-01 | tho | |||
hl7.fhir.us.mcode | R4 | mcode-treatment-termination-reason-vs | Treatment Termination Reason Value Set | active | 3 | cic | 2025-02 | hl7 | sct |
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.950 | Passed Failed Unknown | active | 2008-01 | sct tho | |||
hl7.fhir.us.carin-bb | R4 | FDANDCOrCompound | NDC or Compound Value Set | trial-use | fm | 2025-02 | hl7 | fhir ndc | |
hl7.fhir.us.davinci-pdex-plan-net | R4 | HealthcareServiceTypeVS | HealthcareService Types VS | trial-use | fm | 2025-02 | hl7 | tho | |
hl7.fhir.us.birthdefectreporting | R4 | ValueSet-admission-status | Admission Status | draft | pher | 2025-06 | hl7 | fhir | |
hl7.fhir.us.birthdefectreporting | R4 | ValueSet-discharged-status | Discharged Status | draft | pher | 2025-06 | hl7 | fhir | |
hl7.fhir.us.birthdefectreporting | R4 | ValueSet-patient-location-types | Patient Location Types | draft | pher | 2025-06 | hl7 | fhir | |
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.5021 | Original Specimen Source Site PHLIP (PLT212) | active | 2011-01 | sct | |||
rapportendoscopiequebec.test | R4 | ValueSet-yes-no-unknown-not-applicable | ValueSet - Yes No Unknown NotApplicable | active | 2023-09 | hl7 | tho | ||
hl7.fhir.us.registry-protocols | R4 | ValvularDiseaseRegurgitationSeverity | Valvular Disease Regurgitation Severity | active | cic | 2023-11 | hl7 | fhir | |
hl7.fhir.us.registry-protocols | R4 | ValvularDiseaseStenosisSeverity | Valvular Disease Stenosis Severity | active | cic | 2023-11 | hl7 | fhir | |
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.1048 | Strain Type (VZ) | active | 2008-01 | tho oid | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3155 | Vaccine Manufacturer (VZ) | active | 2008-01 | tho | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3154 | Vaccines Administered (VZ) | active | 2008-01 | cvx tho | |||
hl7.fhir.us.mcode | R4 | mcode-radiotherapy-treatment-location-qualifier-vs | Radiotherapy Treatment Location Qualifier Value Set | active | 3 | cic | 2025-02 | hl7 | fhir sct |
hl7.fhir.us.pacio-rt | R4 | timepoint-service-type-vs | Timepoint Service Type Value Set | active | 2022-10 | hl7 | fhir | ||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7465 | Vector (Zika) | active | 2016-01 | sct | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3342 | Version ID (HL7) | active | 2012-01 | tho | |||
hl7.fhir.us.registry-protocols | R4 | GraftVesselCABGVessel | Graft Vessel CABG Vessel | active | cic | 2023-11 | hl7 | sct | |
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7645 | Vibrio Cholera Biotype (FDD) | active | 2017-01 | sct tho | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7644 | Vibrio Cholera Serotype (FDD) | active | 2017-01 | sct tho | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7643 | Vibrio Species (FDD) | active | 2018-01 | sct oid | |||
fhir.virtually.healthcare | R4 | SmokingStatus | Smoking Status | draft | 2025-08 | hl7 | sct | ||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3063 | Virus Type (Arboviral Disease) | active | 2016-01 | sct | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.1054 | Volume Mass Units | active | 2008-01 | ucum | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.1053 | Volume Units | active | 2008-01 | ucum | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7374 | Place of Injury (NCHS) | active | 2015-01 | tho oid | |||
hl7.fhir.us.registry-protocols | R4 | CardiacRehabilitationReferral | Cardiac Rehabilitation Referral | active | cic | 2023-11 | hl7 | fhir | |
signal.core.r4 | R4 | questionnaire-dacods-statutory-commitment | Questionnaire DACODS Statutory Commitment | draft | 1 | pa | hl7 | ||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7818 | General Condition Status (TB) | active | 2018-01 | sct | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3113 | Water Salinity (FDD) | active | 2008-01 | sct tho | |||
fhir.nhs.uk.wayfinder | R4 | 07b2b166-ed9d-45be-9798-d80be433f15b | Wayfinder CarePlan Activity Detail Kind | draft | hl7 | fhir | |||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.96 | Salmonellosis [Salmonella Species and Subspecies] (Organism or Substance in Lab Results) | active | 2024-06 | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1196.94 | CPIC RxNORM allopurinol SCDG | active | 2019-05 | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1196.93 | CPIC RxNORM abacavir SCDG | active | 2019-05 | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1196.99 | CPIC RxNORM capecitabine SCDG | active | 2019-05 | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1196.97 | CPIC RxNORM atomoxetine SCDG | active | 2019-05 | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1196.95 | CPIC RxNORM amitriptyline SCDG | active | 2019-05 | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1196.96 | CPIC RxNORM atazanavir SCDG | active | 2019-05 | hl7 | rx | ||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3114 | Well Water Treatment (FDD) | active | 2008-01 | tho oid | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7834 | Medication Received (TBRD) | active | 2018-01 | rx tho | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7614 | Case Appraisal (CRS) | active | 2017-01 | sct oid | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7749 | Smoking Status | active | 2017-12 | sct | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.8003 | Smoking Status (Anthrax) | active | 2020-01 | sct tho | |||
hl7.fhir.us.davinci-vbpr | R4 | vbp-incentive | Incentive | trial-use | 1 | cqi | 2025-07 | hl7 | fhir |
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7607 | Type of Testing at CDC | active | 2017-01 | sct tho | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7659 | Type of Testing at CDC(Rubella) | active | 2017-01 | sct tho | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7274 | Death Pronouncement Procedure (NCHS) | active | 2015-01 | sct | |||
hl7.fhir.us.breastcancer | R3 | oncology-StageTimingPrefixVS | BC StageTimingPrefixVS ValueSet | draft | 2018-08 | hl7 | fhir | ||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3099 | Seafood Purchase Info (FDD) | active | 2008-01 | sct tho oid | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3092 | Meat Purchase Info (FDD) | active | 2008-01 | sct tho oid | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7359 | Point of Origin (NCHS) | active | 2015-01 | sct tho oid | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.1033 | Rash Location First Noted (VZ) | active | 2008-01 | sct tho oid | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7670 | Meat Purchase Info (Trich) | active | 2018-01 | sct tho oid | |||
signal.core.r4 | R4 | questionnaire-ccars-history-current-victimization | Questionnaire CCARS History Current Victimization | draft | 1 | pa | hl7 | ||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7820 | Born in the United States (Listeria) | active | 2018-01 | sct oid | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7679 | Pregnancy Status (RIBD) | active | 2018-01 | sct tho | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3137 | Prenatal Care Provider (Rubella) | active | 2008-01 | tho oid | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3061 | Public Private Lab | active | 2008-01 | tho oid | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.837 | Ethnicity group | active | 2008-01 | oid | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3106 | Travel Destination Type | active | 2008-01 | tho | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7544 | Outdoor Activities | active | 2016-01 | sct tho | |||
signal.core.r4 | R4 | contact-attempt-results | Contact Attempt Results | draft | 1 | pa | hl7 | ||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3598 | Wound Depth Tetanus (NETSS) | active | 2011-01 | tho oid | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3115 | Wound History | active | 2008-01 | tho oid | |||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1181.14 | Wound anatomic location value set (foundation metadata concept) | active | 2024-06 | hl7 | sct | ||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7226 | X-Ray Result (CS) | active | 2020-01 | tho oid | |||
hl7.fhir.us.carin-bb | R4 | X12ClaimAdjustmentReasonCodesCMSRemittanceAdviceRemarkCodes | X12 Claim Adjustment Reason Codes - Remittance Advice Remark Codes Value Set | trial-use | fm | 2025-02 | hl7 | x12 | |
hl7.fhir.us.davinci-pdex | R4 | X12ClaimAdjustmentReasonCodesCMSRemittanceAdviceRemarkCodes | X12 Claim Adjustment Reason Codes - Remittance Advice Remark Codes | trial-use | 2 | fm | 2025-06 | hl7 | x12 |
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3064 | Yes No Unknown No Answer | active | 2008-01 | tho | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3069 | Yes No Unknown Not Done | active | 2008-01 | sct tho | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7803 | Yes No Unknown Refused (Listeria) | active | 2018-01 | tho oid | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7547 | IgM Ab Tests (Zika) | active | 2016-01 | loinc | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7546 | NAT Tests (Zika) | active | 2016-01 | loinc | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7483 | Signs Symptoms Dengue ICD-10 CM | active | 2016-01 | icd | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7484 | Signs Symptoms Chikungunya ICD-10 CM | active | 2016-01 | icd | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7485 | Signs Symptoms Zika ICD-10 CM | active | 2016-01 | icd | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7548 | Neutralizing Ab Tests (Zika) | active | 2016-01 | loinc | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7457 | Zika-affected areas | active | 2016-01 | iso | |||
signal.core.r4 | R4 | us-core-discharge-disposition | US Core Discharge Disposition | active | 2022-09 | hl7 | |||
hl7.fhir.us.pacio-adi | R4 | ADIDocumentRevokeStatusVS | ADI Document Revoke Status | trial-use | 2 | pe | 2025-08 | hl7 | fhir |
hl7.fhir.us.pacio-adi | R4 | ADICompositionStatusVS | ADI Composition Status | trial-use | 2 | pe | 2025-08 | hl7 | fhir |
hl7.fhir.us.pacio-adi | R4 | ADIDocumentReferenceStatusVS | ADI Document Reference Status | trial-use | 2 | pe | 2025-08 | hl7 | fhir |
us.nlm.vsac | R4 | 2.16.840.1.114222.24.7.280 | NHSNGenotypicTests | active | 2024-08 | hl7 | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.11.20.9.58 | Wound Characteristic | active | 2023-07 | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.1.11.10637 | PostalAddressUse | active | 2024-06 | hl7 | tho | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.1.11.19717 | No Immunization Reason | active | 2024-06 | hl7 | tho | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.11.20.9.23 | Planned moodCode (Act/Encounter/Procedure) | active | 2024-06 | hl7 | tho | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.1.11.20.2.5 | Wound Measurements | active | 2024-06 | hl7 | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.1.11.20.2.6 | Wound Type | active | 2023-07 | hl7 | sct | ||
hl7.fhir.us.registry-protocols | R4 | CardiacValves | Cardiac Valves | active | cic | 2023-11 | hl7 | sct | |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1235.628 | b.well Adult RSV Vaccine CN_CVX | active | 2025-03 | hl7 | cvx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1235.629 | b.well Adult RSV Vaccine CN_CPT | active | 2025-03 | hl7 | cpt | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1235.630 | b.well Adult RSV Vaccine CN_HCPCS | active | 2025-03 | hl7 | cms | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1235.631 | b.well Adult RSV Vaccine CN_SNOMED | active | 2025-03 | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1235.642 | b.well Adult Tetanus Vaccine CN_Exclusions_SNOMED | active | 2025-04 | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1235.643 | b.well Adult Tetanus Vaccine CN_Exclusions | active | 2025-04 | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1235.640 | b.well Adult Tetanus Vaccine CN_CPT | active | 2025-04 | hl7 | cpt | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1235.641 | b.well Adult Tetanus Vaccine CN_CVX | active | 2025-04 | hl7 | cvx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1235.644 | BWellAdultTetanusVaccineCN_RxNorm | active | 2025-04 | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1235.639 | BWellAdultTetanusVaccineCN_SNOMED | active | 2025-04 | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1235.92 | Cardiomyopathy Dilated ICD10 | active | 2025-02 | hl7 | icd |